Top Shorted Stocks in Hong Kong: S&P Global Market Intelligence identified the ten most shorted stocks in Hong Kong, with metrics including the number of shares borrowed and short selling ratios.

Notable Stocks: Key stocks include Ping An with a short selling ratio of 39.57%, COSCO Ship Hold at 23.71%, and Hengrui Pharma at 18.79%, reflecting significant investor skepticism.

Market Trends: The report indicates a mixed performance in stock prices over the past week, with some stocks experiencing gains while others faced declines.

Market Insights: Analysts, including those from M Stanley, suggest that the recent uptrend in the Chinese property sector may not be sustainable, predicting potential declines in home sales and prices.

Hong Kong's AI Development Environment: Hong Kong is recognized as a vibrant and internationalized hub for AI companies, facilitating business expansion and innovation, according to Shen Jianguang, Vice President and Chief Economist of JD-SW.

Strategic Advantages in AI: The city is expected to leverage its rapid AI infrastructure development to enhance its position in data science, fintech, and intelligent manufacturing, serving as a bridge between mainland China and global markets.

Biomedical Technology Cooperation: Dai Hongbin, Vice Chairman of HENGRUI PHARMA, emphasized the importance of Hong Kong's strategic role in the international innovation ecosystem and expressed interest in collaborating with the Office for Attracting Strategic Enterprises to advance biomedical technology.

Market Activity: The article notes current short selling statistics for Hong Kong stocks, indicating significant market activity, with specific figures for JD-SW and HENGRUI PHARMA.

Revenue Forecast Adjustment: Morgan Stanley has lowered its total revenue forecasts for HENGRUI PHARMA for 2025-2027 by 2.1%, 3.7%, and 1.8% due to decreased commercial development income from GlaxoSmithKline assets and a decline in the generic drug business.

Net Profit Forecast Reduction: The broker also reduced its net profit forecasts for the same period by 7.4%, 8.9%, and 6.5%, although this was partially offset by higher forecasts for innovative drug sales.

Target Price Increase: Despite the lowered forecasts, Morgan Stanley raised its target price for HENGRUI PHARMA from $86 to $92, maintaining an Overweight rating.

Market Activity: The stock experienced a short selling of $25.50 million, with a short selling ratio of 25.531%.

Top Shorted Stocks: S&P Global Market Intelligence identified the ten most shorted stocks in Hong Kong, with metrics based on the short selling ratio, which measures shares lent out relative to total issued shares.

Leading Stocks: COSCO SHIP HOLD topped the list with a short selling ratio of 40.396%, followed by DONGFANG ELEC and PHARMARON with ratios of 19.528% and 34.783%, respectively.

Stock Performance: The report includes recent price changes and short selling amounts, indicating varying performance among the listed stocks over the past week.

Market Insights: The data reflects investor sentiment and market dynamics, with significant short selling activity observed in companies like PING AN and ZTE, highlighting potential concerns or speculation in the market.

Market Performance: The HSI closed down 11 points at 26,552, with the HSCEI and HSTECH also experiencing slight declines. Total market turnover for the half-day was HKD129.845 billion.

Tech Stock Movements: Major tech stocks like TENCENT and BIDU-SW fell by approximately 1.5%, while JD-SW and BILIBILI-W saw gains of around 1.1% and 1.2%, respectively.

Sector Highlights: Consumer stocks performed well, with POP MART surging 8.5% after announcing a share buyback, while pharmaceutical stocks like HENGRUI PHARMA and WUXI APPTEC faced significant declines.

Economic Indicators: China's Fixed Asset Investment for December showed a year-on-year decrease of -3.8%, and the GDP growth rate for Q4 was reported at 4.5%, slightly below expectations.